Bromocriptine-induced schizophrenia

J Natl Med Assoc. 1993 Sep;85(9):700-1.


A 53-year-old male, without any prior history of psychosis, developed schizophrenia 4 days after starting low-dose bromocriptine therapy for a macroprolactinoma. Five days after discontinuation of this medication his mental status returned to normal. This case is reported in support of the dopamine hypothesis for the etiology of schizophrenia.

Publication types

  • Case Reports

MeSH terms

  • Bromocriptine / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Pituitary Neoplasms / drug therapy
  • Prolactinoma / drug therapy
  • Schizophrenia / chemically induced*


  • Bromocriptine